|
1
|
Wang T, Gui W and Shen Q: Primary
gastrointestinal non-Hodgkin's lymphoma: clinicopathological and
prognostic analysis. Med Oncol. 27:661–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herrmann R, Panahon AM, Barcos MP, Walsh D
and Stutzman L: Gastrointestinal involvement in non-Hodgkin's
lymphoma. Cancer. 46:215–222. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Krieken JH, Otter R, Hermans J, et al:
Malignant lymphoma of the gastrointestinal tract and mesentery. A
clinico-pathologic study of the significance of histologic
classification. NHL Study Group of the Comprehensive Cancer Center
West. Am J Pathol. 135:281–289. 1989.PubMed/NCBI
|
|
4
|
Chen F, Yang G and Xia B: Increased
expression of the spindle checkpoint protein BubR1 is associated
with high cell proliferation in primary gastrointestinal diffuse
large B cell lymphoma. Cell Biochem Biophys. 66:747–752. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding D, Pei W, Chen W, Zuo Y and Ren S:
Analysis of clinical characteristics, diagnosis, treatment and
prognosis of 46 patients with primary gastrointestinal non-Hodgkin
lymphoma. Mol Clin Oncol. 2:259–264. 2014.PubMed/NCBI
|
|
6
|
Li X, Shen W, Cao J, et al: Treatment of
gastrointestinal diffuse large B cell lymphoma in China: a 10-year
retrospective study of 114 cases. Ann Hematol. 91:1721–1729. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Robertson KD: DNA methylation,
methyltransferases, and cancer. Oncogene. 20:3139–3155. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
9
|
Fitzpatrick DR and Wilson CB: Methylation
and demethylation in the regulation of genes, cells, and responses
in the immune system. Clin Immunol. 109:37–45. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatemi M, Hermann A, Gowher H and Jeltsch
A: Dnmt3a and Dnmt1 functionally cooperate during de novo
methylation of DNA. Eur J Biochem. 269:4981–4984. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT
and Wang YC: Alteration of DNA methyltransferases contributes to
5′CpG methylation and poor prognosis in lung cancer. Lung Cancer.
55:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saito Y, Kanai Y, Nakagawa T, et al:
Increased protein expression of DNA methyltransferase (DNMT) 1 is
significantly correlated with the malignant potential and poor
prognosis of human hepatocellular carcinomas. Int J Cancer.
105:527–532. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oue N, Kuraoka K, Kuniyasu H, et al: DNA
methylation status of hMLH1, p16(INK4a), and CDH1 is not associated
with mRNA expression levels of DNA methyltransferase and DNA
demethylase in gastric carcinomas. Oncol Rep. 8:1085–1089.
2001.PubMed/NCBI
|
|
14
|
Girault I, Tozlu S, Lidereau R and Bieche
I: Expression analysis of DNA methyltransferases 1, 3A, and 3B in
sporadic breast carcinomas. Clin Cancer Res. 9:4415–4122.
2003.PubMed/NCBI
|
|
15
|
Xing J, Stewart DJ, Gu J, Lu C, Spitz MR
and Wu X: Expression of methylation-related genes is associated
with overall survival in patients with non-small cell lung cancer.
Br J Cancer. 98:1716–1722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayette S, Thomas X, Jallades L, et al:
High DNA methyltransferase DNMT3B levels: poor prognostic marker in
acute myeloid leukemia. PLoS One. 7:e515272012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bai X, Song Z, Fu Y, et al:
Clinicopathological significance and prognostic value of DNA
methyltransferase 1, 3a, and 3b expressions in sporadic epithelial
ovarian cancer. PLoS One. 7:e400242012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shaknovich R and Melnick A: Epigenetics
and B-cell lymphoma. Curr Opin Hematol. 18:293–299. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Taylor KH, Briley A, Wang Z, Cheng J, Shi
H and Caldwell CW: Aberrant epigenetic gene regulation in lymphoid
malignancies. Semin Hematol. 50:38–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De S, Shaknovich R, Riester M, et al:
Aberration in DNA methylation in B-cell lymphomas has a complex
origin and increases with disease severity. PLoS Genet.
9:e10031372013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pike BL, Greiner TC, Wang X, et al: DNA
methylation profiles in diffuse large B-cell lymphoma and their
relationship to gene expression status. Leukemia. 22:1035–1043.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Asmar F, Punj V, Christensen J, et al:
Genome-wide profiling identifies a DNA methylation signature that
associates with TET2 mutations in diffuse large B-cell lymphoma.
Haematologica. 98:1912–1920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tomonaga M.: Outline and direction of
revised WHO classification of tumors of haematopoietic and lymphoid
tissues. Rinsho Ketsueki. 50:1401–1406. 2009.(In Japanese).
PubMed/NCBI
|
|
24
|
No authors listed: 5th International
Conference on Malignant Lymphoma, Part 2. Proceedings. Lugano,
Switzerland, June 9–12, 1993. Ann Oncol. 5 (Suppl 2):S1–S163.
1994.PubMed/NCBI
|
|
25
|
Hans CP, Weisenburger DD, Greiner TC, et
al: Confirmation of the molecular classification of diffuse large
B-cell lymphoma by immunohistochemistry using a tissue microarray.
Blood. 103:275–282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheson BD, Horning SJ, Coiffier B, et al:
Report of an international workshop to standardize response
criteria for non-Hodgkin's lymphomas. NCI Sponsored International
Working Group. J Clin Oncol. 17:12441999.PubMed/NCBI
|
|
27
|
Fukushige S and Horii A: DNA methylation
in cancer: a gene silencing mechanism and the clinical potential of
its biomarkers. Tohoku J Exp Med. 229:173–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sincic N and Herceg Z: DNA methylation and
cancer: ghosts and angels above the genes. Curr Opin Oncol.
23:69–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mutze K, Langer R, Schumacher F, et al:
DNA methyltransferase 1 as a predictive biomarker and potential
therapeutic target for chemotherapy in gastric cancer. Eur J
Cancer. 47:1817–1825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen W, Gao N, Shen Y and Cen JN:
Hypermethylation downregulates Runx3 gene expression and its
restoration suppresses gastric epithelial cell growth by inducing
p27 and caspase3 in human gastric cancer. J Gastroenterol Hepatol.
25:823–831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao P, Yang X, Xue YW, Zhang XF, Wang Y,
Liu WJ and Wu XJ: Promoter methylation of glutathione S-transferase
pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma
and its correlation with DNA methyltransferase 1 expression.
Cancer. 115:3222–3232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xing J, Stewart DJ, Gu J, Lu C, Spitz MR
and Wu X: Expression of methylation-related genes is associated
with overall survival in patients with non-small cell lung cancer.
Br J Cancer. 98:1716–1722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim H, Kwon YM, Kim JS, Han J, Shim YM,
Park J and Kim DH: Elevated mRNA levels of DNA methyltransferase-1
as an independent prognostic factor in primary non-small cell lung
cancer. Cancer. 107:1042–1049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vallbohmer D, Brabender J, Yang D, et al:
DNA methyltransferases messenger RNA expression and aberrant
methylation of CpG islands in non-small-cell lung cancer:
association and prognostic value. Clin Lung Cancer. 8:39–44. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang W, Gao J, Man XH, Li ZS and Gong YF:
Significance of DNA methyltransferase-1 and histone deacetylase-1
in pancreatic cancer. Oncol Rep. 21:1439–1447. 2009.PubMed/NCBI
|
|
36
|
Kreth S, Thon N, Eigenbrod S, et al:
O-methylguanine-DNA methyltransferase (MGMT) mRNA expression
predicts outcome in malignant glioma independent of MGMT promoter
methylation. PLoS One. 6:e171562011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Amara K, Ziadi S, Hachana M, Soltani N,
Korbi S and Trimeche M: DNA methyltransferase DNMT3b protein
overexpression as a prognostic factor in patients with diffuse
large B-cell lymphomas. Cancer Sci. 101:1722–1730. 2010. View Article : Google Scholar : PubMed/NCBI
|
